Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 48

1.

Pharmacotherapy for the metabolic syndrome.

Swislocki AL, Siegel D, Jialal I.

Curr Vasc Pharmacol. 2012 Mar;10(2):187-205. Review.

PMID:
22022773
[PubMed - indexed for MEDLINE]
2.

Long-term maintenance of glucose control in veterans with type 2 diabetes mellitus using oral agents.

Swislocki AL, Meier JL, Najera SM, Noth RH.

Metab Syndr Relat Disord. 2011 Dec;9(6):469-73. doi: 10.1089/met.2011.0038. Epub 2011 Aug 24.

PMID:
21864034
[PubMed - indexed for MEDLINE]
3.

Resistant hypertension and undiagnosed primary hyperaldosteronism detected by use of a computerized database.

Garcia EA, Lopez JR, Meier JL, Swislocki AL, Siegel D.

J Clin Hypertens (Greenwich). 2011 Jul;13(7):487-91. doi: 10.1111/j.1751-7176.2011.00443.x. Epub 2011 Mar 28.

PMID:
21762361
[PubMed - indexed for MEDLINE]
4.

The ACCORD Study: the devil is in the details.

Siegel D, Swislocki AL.

Metab Syndr Relat Disord. 2011 Apr;9(2):81-4. doi: 10.1089/met.2010.0119. Epub 2010 Dec 18.

PMID:
21166575
[PubMed - indexed for MEDLINE]
5.

Hypertensive treatment in patients with metabolic syndrome.

Siegel D, Swislocki AL.

Metab Syndr Relat Disord. 2010 Apr;8(2):95-104. doi: 10.1089/met.2009.0086. Review.

PMID:
20156078
[PubMed - indexed for MEDLINE]
6.

The effect of body mass index on fasting blood glucose and development of diabetes mellitus after initiation of extended-release niacin.

Libby A, Meier J, Lopez J, Swislocki AL, Siegel D.

Metab Syndr Relat Disord. 2010 Feb;8(1):79-84. doi: 10.1089/met.2009.0074.

PMID:
19943800
[PubMed - indexed for MEDLINE]
7.

Computer-based screening of veterans for metabolic syndrome.

Keane J, Meier JL, Noth RH, Swislocki AL.

Metab Syndr Relat Disord. 2009 Dec;7(6):557-61. doi: 10.1089/met.2009.0021.

PMID:
19558266
[PubMed - indexed for MEDLINE]
8.

Smokeless nicotine exposure has no lasting effect on fasting or postglucose circulation leptin in young rats.

Swislocki AL, Fakiri Z.

Metab Syndr Relat Disord. 2008 Dec;6(4):257-62. doi: 10.1089/met.2008.0017.

PMID:
19067528
[PubMed - indexed for MEDLINE]
9.

Effects of antihypertensives on glucose metabolism.

Siegel D, Swislocki AL.

Metab Syndr Relat Disord. 2007 Sep;5(3):211-9. doi: 10.1089/met.2007.0016.

PMID:
18370775
[PubMed]
10.

The effect of body mass index on fasting blood glucose after initiation of thiazide therapy in hypertensive patients.

Siegel D, Meier J, Maas C, Lopez J, Swislocki AL.

Am J Hypertens. 2008 Apr;21(4):438-42. doi: 10.1038/ajh.2007.75. Epub 2008 Jan 31.

PMID:
18246056
[PubMed - indexed for MEDLINE]
11.

The stumble-from pipe cleaner to bone builder.

Swislocki AL, Wexler JA.

Endocr Pract. 2007 Mar-Apr;13(2):194-7. Review.

PMID:
17490936
[PubMed - indexed for MEDLINE]
12.

Adoption of a new technology in a Veterans Affairs national formulary system with local implementation: the insulin glargine example.

Barengolts EI, Burke BV, Duckworth WC, Kaminsky R, Miller DR, Swislocki AL.

Manag Care Interface. 2007 Mar;20(3):37-44, 57.

PMID:
17458480
[PubMed - indexed for MEDLINE]
13.
14.

Reduction in self-monitoring of blood glucose in persons with type 2 diabetes results in cost savings and no change in glycemic control.

Meier JL, Swislocki AL, Lopez JR, Noth RH, Bartlebaugh P, Siegel D.

Am J Manag Care. 2002 Jun;8(6):557-65.

PMID:
12068962
[PubMed - indexed for MEDLINE]
Free Article
15.

Voluntary running improves glucose tolerance and insulin resistance in female spontaneously hypertensive rats.

LaPier TL, Swislocki AL, Clark RJ, Rodnick KJ.

Am J Hypertens. 2001 Jul;14(7 Pt 1):708-15.

PMID:
11465658
[PubMed - indexed for MEDLINE]
16.

Renal effects of angiotensin-converting enzyme inhibitors that result in cost savings and improved patient outcomes.

Swislocki AL, Siegel D.

Am J Manag Care. 2001 Mar;7(3):283-95. Review.

PMID:
11258145
[PubMed - indexed for MEDLINE]
Free Article
17.

Metabolic, hemodynamic, and cardiac effects of captopril in young, spontaneously hypertensive rats.

Swislocki AL, LaPier TL, Khuu DT, Fann KY, Tait M, Rodnick KJ.

Am J Hypertens. 1999 Jun;12(6):581-9.

PMID:
10371367
[PubMed - indexed for MEDLINE]
18.

Safety and efficacy of metformin in a restricted formulary.

Swislocki AL, Khuu Q, Liao E, Wu E, Beza F, Lopez J, Kwan G, Noth RH.

Am J Manag Care. 1999 Jan;5(1):62-8.

PMID:
10345968
[PubMed - indexed for MEDLINE]
Free Article
19.

Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Siegel D, Swislocki AL.

JAMA. 1999 Feb 3;281(5):417-9. No abstract available.

PMID:
9952198
[PubMed - indexed for MEDLINE]
20.

Case report. Pseudohepatotoxicity of metformin.

Swislocki AL, Noth R.

Diabetes Care. 1998 Apr;21(4):677-8. No abstract available.

PMID:
9571371
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk